Contraceptives Market Analysis

Contraceptives Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is classified into drugs and devices. The devices segment generated the highest revenue of USD 16 billion in 2023.
 

• Devices such as intrauterine devices (IUDs), contraceptive implants, and vaginal rings provide prolonged protection, often lasting several years without requiring daily or monthly attention. This reliability and ease of use make them appealing to women seeking consistent and low-maintenance birth control. IUDs, for example, are among the most effective forms of contraception, with a failure rate of less than 1%, providing a high level of confidence for users.
   
• Furthermore, the growing awareness of the benefits of non-hormonal contraceptive devices, such as copper IUDs, has expanded the market. These devices cater to women who prefer to avoid hormonal side effects, offering a viable alternative while maintaining high efficacy. The increasing availability of different device options in healthcare settings, along with rising government initiatives promoting LARCs, has further propelled the market for contraceptive devices.
   

Based on age group, the contraceptives market is categorized into 15-44 years and above 44 years. The 15-44 years segment generated the highest revenue of USD 21.3 billion in 2023.
 

• The age group 15-44 years dominated the market, as this is the most fertile and sexually active demographic, making contraception a critical aspect of their reproductive health management. Individuals in this age group are more likely to be concerned about preventing unwanted pregnancies while planning for family-building later in life. With increasing awareness about family planning and sexual health, there is a higher adoption rate of contraceptives among individuals within this age group.
   
• Further, gradual shift in socio-cultural dynamics, with more women focusing on careers and delaying childbearing are also one of the prominent factors for segment growth. This has increased the use of contraceptive methods to manage reproductive health and plan pregnancies according to personal and professional goals. Healthcare providers and government bodies also target this age group for family planning initiatives and contraceptive distribution programs, increasing access to birth control products.
   

Based on distribution channel, the contraceptives market is segmented into retail pharmacies, hospital pharmacies, online channels, and other distribution channels. The retail segment dominated the market in 2023 and is anticipated to reach USD 18.3 billion by the end of the forecast period.
 

• Consumers find retail pharmacies to be convenient sources for purchasing contraceptives, including over-the-counter products such as condoms and emergency contraceptive pills. The availability of contraceptive drugs, such as oral pills and patches, at retail pharmacies further drives their dominance in the market. Many consumers prefer retail pharmacies for the ease of access, consultation with pharmacists, and the ability to purchase products without the need for a doctor's appointment.
   
• In addition, retail pharmacies have expanded their product offerings to include a variety of contraceptive products, both prescription-based and non-prescription. This variety allows consumers to explore different options based on their preferences and needs. The growth of chain pharmacies and the presence of dedicated health sections in major retail stores also contribute to the increased market share of this segment.
   

North America contraceptives market accounted for USD 7.5 billion market revenue in 2023 and is anticipated to grow at a CAGR of 4% between 2024 and 2032.
 

• The contraceptive market in North America is growing due to rising awareness of family planning and reproductive health, supported by government initiatives and healthcare policies. In countries like Canada, access to contraceptive products is widely available through both public and private healthcare systems. Educational campaigns focused on sexual health also contribute to higher adoption rates, particularly among younger women.
   
• In addition, increasing demand for long-acting reversible contraceptives (LARCs) like IUDs has also driven the contraceptive market in North America. The healthcare system's support for family planning services, combined with a growing number of clinics and providers offering affordable contraceptive options, enhances accessibility.
   

U.S. contraceptives market accounted for USD 7.2 billion market revenue in 2023 and is estimated to hold substantial share between 2024 and 2032.
 

• The growth of the U.S. contraceptive market is growing due to increasing awareness of sexual health and reproductive rights. The Affordable Care Act (ACA) has played a significant role in expanding access to contraceptives, particularly by providing insurance coverage for various birth control methods. This has encouraged women across different age groups to explore contraception as part of their healthcare routine.
   
• Moreover, the market has experienced significant growth due to increasing demand for innovative contraceptive products, such as extended-release contraceptives and implants. For instance, the FDA in July 2023 approved the first non-prescription daily oral contraceptive in the U.S., developed by Perrigo Company plc. This milestone reflects broader industry efforts, as manufacturers are heavily investing in research and development to introduce more convenient and less invasive contraceptive options, thereby improving accessibility to safe and effective birth control for a wider population.
   

UK contraceptives market is projected to grow substantially in the coming years.
 

• The contraceptive market in the UK is driven by the National Health Service's (NHS) comprehensive birth control offerings, which provide free access to various contraceptive methods. The government's proactive stance on family planning and its support for reproductive health have contributed to high adoption rates. Public health campaigns on safe sex and contraception further fuel demand, especially among younger women.
   
• In addition, the UK's focus on promoting LARCs, such as IUDs and contraceptive implants, has significantly impacted the market. The rising demand for long-term contraceptive methods, coupled with the availability of newer options, has driven growth in the contraceptive market in the UK.
   

Japan holds a dominant position in the Asia Pacific contraceptives market.
 

• Japan’s contraceptive market is relatively small compared to Western countries, but it has seen steady growth in recent years due to changing social attitudes toward family planning and increased awareness about reproductive health. The government has introduced educational programs to raise awareness of contraception among the younger population, which has led to a gradual increase in adoption rates. In Japan, oral contraceptives and condoms are the most popular methods of birth control, largely due to their ease of use and cultural acceptance.
   
• The growing influence of Western family planning methods, along with greater availability of contraceptive products, has also contributed to the market’s expansion. Additionally, Japan has seen a rise in demand for emergency contraceptive pills, especially among younger women, further contributing to the growth of the contraceptive market in the country.